Andere Sprachen Biovica International AB

Aktien

A2DPS4

SE0008613731

BIOVIC B

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 17:29:38 26.04.2024			% 5 Tage	% 1. Jan.
1,706 ^SEK	+6,36 %		-22,81 %	-33,88 %

12.04.	Biovica International AB (Publ) kündigt Divitum® Tka in Beobachtungsstudie an	CI
11.04.	Biovica International AB (Publ) kündigt Ernennungen für den Nominierungsausschuss an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Biovica saves SEK 30 million year and investigates new go-to market model in US	24.04.
Biovica saves SEK 30 million/year and investigates new go-to market model in US	23.04.
Biovica - DiviTum TKa in observational trial	15.04.
DiviTum TKa in Observational Trial	15.04.
Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024.	13.04.
DiviTum® TKa in observational trial	12.04.
Biovica International AB Announces Divitum® Tka in Observational Trial	12.04.
Biovica International AB Announces Appointments to the Nomination Committee	11.04.
Nomination Committee for Biovica International AB for the 2024 Annual General Meeting	11.04.
Biovica receives positive patent notification for immunotherapies	19.03.
Biovica - Commercial progress despite a quarter with modest sales	18.03.
Q3 Interim Report November-January 2023/2024	14.03.
Biovica International AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	14.03.
Interventional DiviTum® TKa trial launches at Washington University	13.03.
Biovica Announces Interventional DiviTum TKa Trial Launches at Washington University	13.03.
Biovica International Signs SEK 1.2 Million Master Service Agreement	12.03.
Biovica signs master service agreement	12.03.
Biovica Signs Master Service Agreement for Tka Testing with Leading Pharma Company	07.03.
Biovica signs master service agreement for TKa testing with leading pharma company	07.03.
Biovica signs agreement with Palex Group, a market leader in Spain and Portugal	22.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Biovica International AB

Aktien

A2DPS4

SE0008613731

BIOVIC B

Andere Sprachen

Filter